ZY Alert: Monsey Firm of Wohl & Fruchter LLP Investigating Sale of Zymergen to Ginkgo Bioworks
July 25, 2022 12:03 ET | Wohl & Fruchter LLP
MONSEY, New York, July 25, 2022 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Zymergen, Inc. (ticker: ZY) (“Zymergen”) acted in the best...
Zymergen_Logo_Horizontal_Black.png
Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform
July 14, 2022 16:56 ET | Zymergen Inc.
EMERYVILLE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced it has expanded its agreement with Octant to further scale their next-generation...
Jack Gold
Absci Prepares for Next Stage of Growth with Executive Human Resources and Marketing Hires
July 14, 2022 07:05 ET | ABSCI Corporation
VANCOUVER, Wash. and NEW YORK, July 14, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand...
Zymergen_Logo_Horizontal_Black.png
Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications
June 28, 2022 16:05 ET | Zymergen Inc.
EMERYVILLE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”) today announced an R&D supply agreement to provide Zymergen Z2TM polyimide powder to 3D4Makers...
Shiru Logo Green.png
Shiru appoints industry veterans Dean Banks, Aaron Kimball, and Blaine Templeman to advisory board
June 24, 2022 11:02 ET | Shiru
ALAMEDA, Calif., June 24, 2022 (GLOBE NEWSWIRE) -- Food ingredient company Shiru has appointed three new members to its advisory board: Dean Banks, former president and CEO of Tyson Foods, Aaron...
Zymergen_Logo_Horizontal_Black.png
Zymergen Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform
May 26, 2022 16:05 ET | Zymergen Inc.
EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced it has entered into an agreement with Octant for the sale of a modular automation...
Senti Bio Secures Additional Financing from Leaps by Bayer and Provides Update on Proposed Business Combination with Dynamics Special Purpose Corp. (DYNS)
May 24, 2022 08:30 ET | Senti Biosciences, Inc.
- Leaps by Bayer led Series B investment in Senti Bio in 2021; Additional Convertible Note financing expands committed capital to PIPE investment associated with previously announced Business...
Zymergen_Logo_Horizontal_Black.png
Zymergen Reports Preliminary First Quarter 2022 Financial Results
May 12, 2022 16:05 ET | Zymergen Inc.
EMERYVILLE, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen Inc. (“Zymergen” or the “Company”), today reported preliminary financial results for the first quarter ended March...
Logo.png
Tuberculosis Pipeline Landscape Analysis of 38+ Companies by DelveInsight
May 04, 2022 13:00 ET | DelveInsight Business Research LLP
New York, USA, May 04, 2022 (GLOBE NEWSWIRE) -- Tuberculosis Pipeline Landscape Analysis of 38+ Companies by DelveInsight Tuberculosis (TB) is a chronic condition and has become a global disease...
Zymergen_Logo_Horizontal_Black.png
Zymergen to Participate in the BofA Securities 2022 Healthcare Conference
April 29, 2022 08:00 ET | Zymergen Inc.
EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen” or the “Company”), today announced the company will be participating in the upcoming BofA Securities 2022 Healthcare...